A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental Glomerulosclerosis

NCT05213624 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

67

Enrollment

INDUSTRY

Sponsor class

Conditions

Kidney Disease, Chronic

Interventions

DRUG: BI 764198
DRUG: Placebo

Sponsor

Boehringer Ingelheim